It stands out in a region where Amish farms and hills covered with second-growth red-oak woods, parks, and hiking trails ...

About 1 in 6 women were found to experience symptoms of postpartum depression 2 months after cesarean delivery.

BMI has predicted that naira will reach N1,993/$ by 2028, impacting Nigeria’s pharmaceutical industry’s ability to import ...

The winner will be announced Wednesday evening at The American Lawyer's Industry Awards. These attorneys have been named ...

GlaxoSmithKline Pharmaceuticals on Tuesday reported a 16 per cent year-on-year increase in its consolidated net profit to Rs ...

In a report released today, Emily Field from Barclays maintained a Hold rating on GlaxoSmithKline (GSK – Research Report), with a price target of £14.50. The company’s shares closed yesterday at ...

BMI, a Fitch Solutions company, has predicted that the naira would slide to as low as N1,993 to one US dollar in 2028, ...

Kepler Capital analyst David Evans maintained a Hold rating on GlaxoSmithKline (GSK – Research Report) on October 30 and set a price ...

India's GlaxoSmithKline Pharmaceuticals reported a higher second-quarter adjusted profit on Tuesday, driven by strong demand ...

GlaxoSmithKline Pharmaceuticals reports a 16% jump in Q2 net profit to Rs 252 crore, driven by strong sales across segments.

Revenue from operations rose to Rs 1,010 crore for the September quarter compared with Rs 957 crore in the year-ago period, GlaxoSmithKline Pharmaceuticals said in a regulatory filing.

GlaxoSmithKline Pharmaceuticals reported a notable 16% rise in consolidated net profit for the September quarter, reaching Rs 252 crore. This growth was driven by robust sales and brand performance.